Clinica Baviera SAClinica Baviera SAClinica Baviera SA

Clinica Baviera SA

No trades

Documents


Explore the latest documents from the company, including regulatory filings and corporate disclosures that offer insight into company performance and strategy. Use these resources to support informed investment decisions.
Earnings
2025
Earnings, Q4 FY2025
Feb 27, 2026
Revenue and net profit rose double digits, with strong expansion and improved financial position.
Earnings, Q3 FY2025
Nov 25, 2025
Revenue up 16% and EBITDA up 12% year-over-year, with strong expansion and share price growth.
Earnings, Q2 FY2025
Jul 24, 2025
Revenue up 18% to €154.7M; EBITDA and core market growth offset UK and Italy headwinds.
Earnings, Q1 FY2025
May 27, 2025
Revenue up 21% and net income up 4% in Q1 2025, with strong cash position.
2024
Earnings, Q4 FY2024
Feb 28, 2025
Double-digit growth, UK expansion, and higher dividends drive strong 2024 results.
Earnings, Q3 FY2024
Nov 22, 2024
Revenue up 16% and UK expansion via Optimax acquisition mark a growth-focused quarter.
Earnings, Q2 FY2024
Jul 24, 2024
Double-digit growth and a strategic UK acquisition drove strong 1H 2024 results.
Earnings, Q1 FY2024
May 24, 2024
2023
Earnings, Q4 FY2023
Feb 29, 2024
Earnings, Q3 FY2023
Nov 23, 2023
Earnings, Q2 FY2023
Jul 25, 2023
Earnings, Q1 FY2023
Jun 5, 2023
2022
Earnings, Q4 FY2022
Feb 28, 2023
Earnings, Q3 FY2022
Nov 16, 2022
Earnings, Q2 FY2022
Jul 26, 2022
Earnings, Q1 FY2022
May 17, 2022
2021
Earnings, Q4 FY2021
Feb 28, 2022
Earnings, Q3 FY2021
Nov 11, 2021